v' The combined effect upon cerebral blood flow (CBF) of an elevation of cerebrospinal fluid pressure (CSFP) and changes in respiratory CO2 was studied in nine baboons under chloralose anesthesia. The animals were mildly hyperventilated and provided with increasing amounts of COs in O~-air. Arterial CO2 tensions (PaCO2) increased from 17 to 58 mm Hg. Internal carotid blood flow (ICBF) was measured at normal CSFP and at hydrostatically maintained 50 mm Hg CSFP. It was found that: 1) end-tidal CO2 may be used as a substitute for arterial PaCO~ determinations; 2) this elevation of CSFP has little effect on ICBF during hypercapnia and normocapnia; however, 3) during hypocapnia the ICBF is reduced an additional 20% when CSFP is elevated; that is, ICBF is reduced 50% from normal when end-tidal CO2 is reduced to 2% at this elevated level of CSFP.
c ARBON dioxide levels in the blood have a significant influence on cerebral volume and blood flow. A reduction in arterial CO2 tensions (PaCO2) secondary to hyperventilation has been correlated with a reduction in cerebral blood flow (CBF)? , 5-8,1~ The reduction in CBF with hypocapnia, with consequent decrease in intracranial pressure (ICP), serves as the basis for hyperventilation anesthetic techniques. These techniques 1~, 18 have become an accepted practice with neurosurgical patients since a significant reduction in brain size is observed during craniotomy?
Some investigators believe that prolonged hyperventilation with levels of PaCO2 below 25 mm Hg may result in cerebral hypoxia because of the reduction in CBF? ,7'1~ Should cerebral hypoxia occur in this setting, it is possible that it would become more pronounced during marked elevations in ICP, since the latter results in lowering the cerebral perfusion pressure. This effect, however, may be countered by cerebral autoregulation. 1'8'11'~s As the concurrent effect of ICP and CO2 on CBF has not been thoroughly investigated, 8 we believed it would be interesting to determine whether the COs effect on CBF was unaltered during elevated ICP.
In the experiments reported here, PaCOs was varied +20 mm Hg from normal, during mild hyperventilation, by step increases of inspired COs to study the effects of both hypoand hypercapnia on internal carotid blood flow (ICBF). This was done both at normal ICP and with the cerebrospinal fluid pressure (CSFP = ICP) raised to 50 mm Hg. Specifically, the purposes were: 1) to correlate end-tidal CO2 with PaCO2, 2) to determine the effect of increased ICP on ICBF during induced changes in PaCOs, and, therefore, 3) to determine and compare the effects of induced changes of respiratory COs on ICBF at normal and elevated levels of ICP. A preliminary report of these experiments is published elsewhere? 8
Materials and Methods
Baboons were used in this study because the separation of the intracranial and extracranial circulation is similar to that of man. Nine healthy male baboons (10 to 12 kg) were anesthetized initially with an intravenous injection of a short-acting barbiturate. Anesthesia was maintained with intravenous chloralose.
With the animal in a supine position, a polyethylene catheter was inserted into a femoral artery to measure arterial blood pressure (ABP) as well as to withdraw arterial blood for gas analysis. The carotid vessels on one side were exposed, an electromagnetic flowmeter probe 3 mm in internal diameter was applied about the common carotid artery approximately 4 cm proximal to its bifurcation, and the external carotid artery was ligated. Thus, measurement of flow in that common carotid artery represented flow through the internal carotid artery. Both mean and pulsatile blood flow were obtained by a Kolin-Kado electromagnetic flowmeter,* the calibration of which was verified The animal was then placed in a prone position for a lumbar laminectomy; the dura mater and arachnoid were opened under direct vision and two small ureteral catheters were passed into the subarachnoid space in a cephalad direction for approximately 10 cm. One catheter was used to measure CSFP while the other was available for infusing Ringer's solution. Then a ligature was passed around the dural sac just cephalad to the point of entry of the catheters and was tied securely to prevent leakage of spinal fluid. Both CSFP and ABP (both mean and pulsatile) were obtained with Statham transducers.t
An endotracheal-tube cuff was inflated and bilateral thoracotomies were performed. The chest was maintained open to atmospheric pressure throughout the experiment to control respiration with a Harvard respirator.$ A gas-mixing chamber, consisting of tubing 4 in. in diameter and 6 ft in length, was fitted at one end to the air-intake valve of the respirator. The other end of the mixing chamber was open to room air. A l/2-in. diameter tube was then inserted 3 feet into the open end of the chamber. Oxygen was supplied through this tubing at approximately 1 l/min throughout the study. Also, the flow of supplemental CO2 could be varied. This arrangement permitted controlled mixtures of 02 and CO2. Thus, the inspired CO2, and consequently the end-tidal (end-expiratory) CO2 and PaCO2 could be raised in increments by increasing the flow of CO2. The rate and stroke volume of the respirator were adjusted so that the animal was hyperventilated and the PaCOs was stabilized at approximately 18 mm Hg. The respirator then remained unchanged throughout each study. With a constant rate and stroke volume of the respirator, a constant flow of air and Os, and the animal unable to inspire spontaneously, the COs delivery to the animal, and thus the PaCO2, was the experimental variable.
Respiratory gases were continuously sampled through a small catheter placed tStatham transducer, Model P23Db, is manufactured by Statham Instruments, 2230 Statham Boulevard, Oxnard, California 93030.
:~Harvard respirator is manufactured by Harvard Apparatus, 150 Dover Road, Millis, Massachusetts 02054.
within the endotracheal tube. An infrared analyzer,w equipped with a constant-flow pump, was used to determine CO2, thereby providing both inspired CO~ and end-tidal COs concentrations from continuous recordings. Calibration of the CO2 analyzer was carried out before each study.
Arterial blood was sampled intermittently and was analyzed for PaCO~, PaO2, and pH, with a blood gas analyzer. I[ Measurements of ICBF, ABP, CSFP, and airway CO~ concentration were made continuously throughout each study.
Control measurements were made over a 5-minute period, after which an arterial sample was collected from the femoral artery for determination of PaCO~, PaO2, and pH. The procedure was repeated after 5 minutes to evaluate the stability of the control measurements. After withdrawing the second blood sample, COs was added to the inspired gas to increase the end-tidal CO2 concentration by approximately 1%. After the animal reached the desired end-tidal CO~ concentration, it breathed this gas mixture for 5 minutes, a sufficient time judging from the data of Shapiro, et al., 17 after which another arterial sample was withdrawn for blood-gas analysis. Similarly, additional increments in end-tidal CO2 concentration were produced in steps of 1% until the end-tidal concentration of COs was approximately 7%. Arterial samples were withdrawn 5 minutes after each increment. Finally, the concentration of CO~ was returned slowly to the control level.
After the animals had adjusted for 5 to 10 minutes, a reservoir of Ringer's solution (warmed to 38 ~ C) was connected to the appropriate subarachnoid catheter. The CSFP was raised to a mean value of 50 mm Hg by elevating the reservoir to the appropriate height. Because in pilot experiments it was noted that the CSFP increased considerably with progressive increments of CO~, the reservoir height was readjusted to maintain the desired constant CSFP. Baseline measure- ments were repeated as before, and were followed by the step increases in COs.
Thus, the relationship between ICBF and CSFP at progressively increasing levels of CO2 was determined at both normal and elevated levels of CSFP. The data at each expired end-tidal CO2 concentration were averaged and the means and their standard error are given in Fig. 1 . In addition, the change in ICBF as a consequence of elevating the CSFP was evaluated at each CO~ level by Student's t test for the paired values obtained from each baboon; this tests the probability that the two values belong to the same population (null hypothesis). Finally, the constancy of the relation between end-tidal CO2 and PaCOs was determined by linear regression analysis individually for each baboon at each level of CSFP (n = 9 • 2 = 18).
Results
The data obtained from nine baboons at normal CSFP (18 mm Hg) and at elevated CSFP (50 mm Hg) are illustrated in Fig. 1 . By increasing the inspired CO2 concentration from 0 to 6% during mild hyperventilation, the end-tidal CO2 concentration increased from 2% to 7%, and this was reflected by the PaCOs, which increased from 17 to 58 mm Hg, and the pH, which changed from 7.7 to 7.2. Figure 1 relates airway and arterial blood CO2 changes. These are linear, as is expected. Only minor changes would be noted in this figure if the data had been plotted by using the PaCOs as abscissa. The correlation between PaCO2 and end-tidal COs, assuming a linear regression, exceeded 0.98 for each of the 18 incremental series. However, slopes and intercepts of the linear regression line varied not only with CSFP but also between animals at each pressure.
The PaO~ was, at all times, adequate for essentially complete saturation of the arterial hemoglobin. Hence, hypoxic conditions during hypocapnia were not likely unless associated with very low CBF.
Although the mean ABP was essentially unchanged by the increase in the inspired CO~, the mean CSFP increased progressively. At normal CSFP it increased from 15 to 23 mm Hg, with the major increase seen above an end-tidal COs of 5%, while at elevated CSFP the increase noted in pilot experiments was eliminated by readjusting the reservoir height to maintain a constant 50 mm Hg.
The mean ICBF increased progressively with higher levels of COs. While the increase above 5% end-tidal CO~ was about the same at both pressures (that is, during hypercapnia), there was a more pronounced increase between 2% and 5% for the measurements at elevated CSFP than at normal CSFP (that is, during hypocapnia). Figure 1 suggests that the means obtained from measurements of ICBF during hypocapnia are not significantly different at both normal pressure and elevated ICP. Statistical evaluation, when the t test is applied to paired values for each baboon, indicates a probability of 1 in 100 (p = 0.01) that the means at 3% end-tidal CO2 belong to the same population; this finding, and the consistently low (p < 0.03) mean values for ICBF at elevated CSFP only during hypocapnia support the conclusion that hypocapnia during the elevated CSFP level tested here reduces CBF more dramatically than during normal CSFP. Reducing the endtidal COs to 3%, from a normal 5%, decreases ICBF by about 24% at normal CSFP and by about 43% at a CSFP of 50 mm Hg; reducing the end-tidal COs to 2%, from a normal 5%, decreases ICBF by about 35% at normal CSFP and by about 52% at a CSFP of 50 mm Hg.
Discussion
This study was oriented toward clinical applicability, especially concerning hyperven-tilation therapy. 4'J2'18 While the inspired COs was varied by the investigators, the rate and depth of breathing were fixed during each experiment by use of a respirator. Because of the mild hyperventilation, the end-tidal COs is close to, but not equal to, alveolar CO2; calculation from the PaCO~ confirms this slight difference. Although physiological behavior is dependent upon the PaCO2, with patients it would be preferable to measure the airway COs continuously to permit noninvasive, repetitive COs determinations.
The results of this study indicate that, even when there is mild hyperventilation, the endtidal COs level may be used in exchange for the PaCO~ to reduce the need for repeated blood samples. For each patient there should be obtained at any one CSFP two correlations between PaCO2 and end-tidal COs in order to define their linear relation: 1) while the patient is at "rest," and 2) during mild induced hyperventilation.
At elevated CSFP the ICBF is reduced slightly more than 50% by hypocapnia from a normal end-tidal CO2 of 5% to 2%. While there is no indication in these experiments that hypoxia occurred, the mean ABP remaining essentially constant and the PaO2 being adequate to maintain the oxygen content of the blood, a patient whose cerebral oxygenation is already barely adequate may become hypoxic with relatively minor degrees of hyperventilation. 7'1~
Caution is therefore advised with patients who have an elevated CSFP and are receiving hyperventilation therapy. Furthermore, it is suggested that hypocapnia to an end-tidal COs of about 3% may be sufficient to obtain the major decrease in ICBF with less possibility for hypoxia than if end-tidal COs is reduced further. This conclusion is in general agreement with observations on man. 5,7,1~ In these experiments, the CSFP was not raised above 50 mm Hg. Consequently, a reflex change of the mean ABP was not expected, and it did remain essentially constant over the range of COs concentrations studied. However, the CSFP increased from 18 to 23 mm Hg with hypercapnia. Such a response to COs has been reported both in patients ~ and, recently, in monkeys? A much more pronounced increase in CSFP (from 22 to 51 mm Hg) has been observed in neurosurgical patients 5 with hypercapnia. This response may well reflect a reduced capacity for compensation in these patients as a result of intracranial disease.
This CSFP response to CO2 suggests that there is a slight increase in intracranial blood volume which accompanies the increase in ICBF and presumably is due to the COsinduced vasodilation. A similar, but larger, increase in CSFP over baseline had been detected with baboons in the present study during pilot experiments at elevated CSFP, just as with monkeys? In the present study, however, the CSFP was held constant at 50 mm Hg by readjusting the height of the reservoir. Consequently, it is possible to relate COs to ICBF at a constant elevated CSFP. Yet, it is not possible to determine the extent by which hypocapnia will lower CSFP from an elevated level.
At normal CSFP and compared to a normal end-tidal COs of 5%, hypocapnia to 2% will reduce mean CSFP by only 2 mm Hg, while hypercapnia to 7% will increase mean CSFP by 5 mm Hg. During normocapnia and hypercapnia, ICBF is approximately the same at 50 mm Hg CSFP as it is at 18 to 23 mm Hg, which indicates that ICBF is controlled more by COs than by the increased CSFP.
In summary, this study reports that:
1. There is a linear correlation between PaCO~ and end-tidal COs, thereby making it possible to substitute a patient's end-tidal COs. The relationship between PaCO2 and end-tidal CO2 may be calibrated by analysis of two arterial blood samples.
2. Elevation of CSFP to 50 mm Hg increases the sensitivity of ICBF to changes in PaCO~. Hypocapnia to an end-tidal COs of 2% decreases ICBF by 35% at normal CSFP and by over 50% at elevated CSFP, while hypercapnia to 7% increases ICBF by over 60% with little difference due to increased ICP.
3. Hyperventilation therapy of patients should be carried out with caution since an elevated CSFP will reduce the ICBF by as much as 20% over that at normal CSFP and increase the possibility of hypoxia.
4. The CSFP may be lowered by hyperventilation hypocapnia and raised by hypercapnia, and this effect is more pronounced when the CSFP is elevated. At normal CSFP, the CSFP is lowered 2 mm Hg by hypocapnia from 5% to 2% end-tidal COs and the CSFP is raised 5 mm Hg by hypercapnia from 5% to 7% end-tidal CO2.
5. Hyperventilation to an end-tidal CO~ of 3% may be sufficient to obtain the major decrease in ICBF and CSFP with reduced danger of hypoxia in patients.
